Stocks
GlaxoSmithKline (GSK) EPS US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | 2.74 | 7.43 | 2.43 | 1.26 | 5.64 | 2.90 | ||
| Changes by years, y/y, % | -5% | +171% | -67% | -48% | +347% | +14.3% | |||
GlaxoSmithKline. EPS, rub
GlaxoSmithKline. EPS, changes, %
GlaxoSmithKline (GSK) EPS US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EPS, rub | ? | 0.79 | 0.71 | 1.00 | 0.63 | 0.86 | 2.90 | |
| Changes by years, y/y, % | +55% | +24% | -3 610% | +212% | +9% | |||
| Changes by quarters, q/q, % | +292% | -11% | +41% | -37% | +36% | |||
